• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶酶体贮积症——视野拓宽。

Lysosomal storage diseases--the horizon expands.

机构信息

Department of Paediatrics and Adolescent Medicine, Biochemistry and Molecular Genetics, American University of Beirut, PO Box 11-0236, Riad El-Solh, 1107 2020, Beirut, Lebanon.

出版信息

Nat Rev Neurol. 2013 Oct;9(10):583-98. doi: 10.1038/nrneurol.2013.163. Epub 2013 Aug 13.

DOI:10.1038/nrneurol.2013.163
PMID:23938739
Abstract

Since the discovery of the lysosome in 1955, advances have been made in understanding the key roles and functions of this organelle. The concept of lysosomal storage diseases (LSDs)--disorders characterized by aberrant, excessive storage of cellular material in lysosomes--developed following the discovery of α-glucosidase deficiency as the cause of Pompe disease in 1963. Great strides have since been made in understanding the pathobiology of LSDs and the neuronal ceroid lipofuscinoses (NCLs). The NCLs are neurodegenerative disorders that display symptoms of cognitive and motor decline, seizures, blindness, early death, and accumulation of lipofuscin in various cell types, and also show some similarities to 'classic' LSDs. Defective lysosomal storage can occur in many cell types, but the CNS and PNS are particularly vulnerable to LSDs and NCLs, being affected in two-thirds of these disorders. Most LSDs are inherited in an autosomal recessive manner, with the exception of X-linked Hunter disease, Fabry disease and Danon disease, and a variant type of adult NCL (Kuf disease). This Review provides a summary of known LSDs, and the pathways affected in these disorders. Existing therapies and barriers to development of novel and improved treatments for LSDs and NCLs are also discussed.

摘要

自 1955 年发现溶酶体以来,人们对该细胞器的关键作用和功能的理解取得了进展。1963 年发现α-葡萄糖苷酶缺乏是庞贝病的病因后,溶酶体贮积症(LSDs)——以溶酶体中细胞物质异常、过度贮积为特征的疾病——的概念得以发展。此后,人们在理解 LSDs 和神经鞘脂褐素沉积症(NCLs)的病理生物学方面取得了巨大进展。NCLs 是神经退行性疾病,表现为认知和运动能力下降、癫痫、失明、早逝以及各种细胞类型中脂褐素的积累,并且与“经典”LSDs 也有一些相似之处。溶酶体贮积缺陷可发生在许多细胞类型中,但中枢神经系统和周围神经系统特别容易受到 LSDs 和 NCLs 的影响,在这些疾病中有三分之二受到影响。大多数 LSDs 以常染色体隐性方式遗传,除 X 连锁亨特病、法布雷病和 Danon 病以及一种变异型成人 NCL(Kuf 病)外。本文综述了已知的 LSDs 以及这些疾病中受影响的途径。还讨论了 LSDs 和 NCLs 的现有治疗方法以及开发新型和改进治疗方法的障碍。

相似文献

1
Lysosomal storage diseases--the horizon expands.溶酶体贮积症——视野拓宽。
Nat Rev Neurol. 2013 Oct;9(10):583-98. doi: 10.1038/nrneurol.2013.163. Epub 2013 Aug 13.
2
Emerging new roles of the lysosome and neuronal ceroid lipofuscinoses.溶酶体和神经细胞蜡样质脂褐质沉积症的新兴新角色。
Mol Neurodegener. 2019 Jan 16;14(1):4. doi: 10.1186/s13024-018-0300-6.
3
Pathomechanisms in the neuronal ceroid lipofuscinoses.神经元蜡样脂褐质沉积症的发病机制。
Biochim Biophys Acta Mol Basis Dis. 2020 Sep 1;1866(9):165570. doi: 10.1016/j.bbadis.2019.165570. Epub 2019 Oct 31.
4
ER and oxidative stresses are common mediators of apoptosis in both neurodegenerative and non-neurodegenerative lysosomal storage disorders and are alleviated by chemical chaperones.内质网应激和氧化应激是神经退行性和非神经退行性溶酶体贮积症中细胞凋亡的常见介质,并可通过化学伴侣予以缓解。
Hum Mol Genet. 2008 Feb 15;17(4):469-77. doi: 10.1093/hmg/ddm324. Epub 2007 Nov 7.
5
Lysosomal Storage Diseases-Regulating Neurodegeneration.溶酶体贮积症与神经退行性变的调控
J Exp Neurosci. 2016 Apr 5;9(Suppl 2):81-91. doi: 10.4137/JEN.S25475. eCollection 2015.
6
Enzyme replacement therapy with recombinant pro-CTSD (cathepsin D) corrects defective proteolysis and autophagy in neuronal ceroid lipofuscinosis.用重组 pro-CTSD(组织蛋白酶 D)进行酶替代疗法可纠正神经细胞蜡样质脂褐质沉积症中的缺陷性蛋白水解和自噬。
Autophagy. 2020 May;16(5):811-825. doi: 10.1080/15548627.2019.1637200. Epub 2019 Jul 16.
7
Impaired autophagy: The collateral damage of lysosomal storage disorders.自噬功能障碍:溶酶体贮积症的附带损伤。
EBioMedicine. 2021 Jan;63:103166. doi: 10.1016/j.ebiom.2020.103166. Epub 2020 Dec 17.
8
Treatment of lysosomal storage disorders: focus on the neuronal ceroid-lipofuscinoses.溶酶体贮积症的治疗:聚焦于神经元蜡样脂褐质沉积症
Acta Neurobiol Exp (Wars). 2008;68(3):429-42. doi: 10.55782/ane-2008-1709.
9
Mass spectrometry-based proteomics in neurodegenerative lysosomal storage disorders.基于质谱的神经退行性溶酶体贮积症蛋白质组学。
Mol Omics. 2022 May 11;18(4):256-278. doi: 10.1039/d2mo00004k.
10
Neuronal genetic rescue normalizes brain network dynamics in a lysosomal storage disorder despite persistent storage accumulation.神经元基因治疗可纠正溶酶体贮积症的脑网络动态,尽管持续存在贮积物积累。
Mol Ther. 2022 Jul 6;30(7):2464-2473. doi: 10.1016/j.ymthe.2022.03.025. Epub 2022 Apr 5.

引用本文的文献

1
Serum N-glycosylation is altered in Nephropathic Cystinosis.肾病性胱氨酸病患者的血清N-糖基化发生改变。
Glycobiology. 2025 Sep 3;35(10). doi: 10.1093/glycob/cwaf047.
2
Induced Pluripotent Stem Cells for the Treatment of Lysosomal Storage Disorders.诱导多能干细胞用于溶酶体贮积症的治疗
J Inherit Metab Dis. 2025 Jul;48(4):e70064. doi: 10.1002/jimd.70064.
3
Nonsense Mutations in Rare and Ultra-Rare Human Disorders: An Overview.罕见和超罕见人类疾病中的无义突变:概述

本文引用的文献

1
Role of the Crosstalk between Autophagy and Apoptosis in Cancer.自噬与细胞凋亡相互作用在癌症发生发展中的作用
J Oncol. 2013;2013:102735. doi: 10.1155/2013/102735. Epub 2013 Jun 5.
2
Downregulated adaptor protein p66(Shc) mitigates autophagy process by low nutrient and enhances apoptotic resistance in human lung adenocarcinoma A549 cells.下调衔接蛋白 p66(Shc) 通过低营养减轻自噬过程,并增强人肺腺癌细胞 A549 的抗凋亡能力。
FEBS J. 2013 Sep;280(18):4522-30. doi: 10.1111/febs.12416. Epub 2013 Jul 25.
3
The eIF2α/ATF4 pathway is essential for stress-induced autophagy gene expression.
IUBMB Life. 2025 Jun;77(6):e70031. doi: 10.1002/iub.70031.
4
Emerging Molecular-Genetic Families in Dystonia: Endosome-Autophagosome-Lysosome and Integrated Stress Response Pathways.肌张力障碍中新兴的分子遗传学家族:内体-自噬体-溶酶体与综合应激反应途径
Mov Disord. 2025 Jan;40(1):7-21. doi: 10.1002/mds.30037. Epub 2024 Oct 28.
5
Oncological Aspects of Lysosomal Storage Diseases.溶酶体贮积症的肿瘤学方面。
Cells. 2024 Oct 8;13(19):1664. doi: 10.3390/cells13191664.
6
High-fidelity imaging of a tumour-associated lysosomal enzyme with an acceptor engineering-boosted near-infrared fluorescent probe.利用受体工程增强型近红外荧光探针实现肿瘤相关溶酶体酶的高保真成像。
Chem Sci. 2024 Apr 16;15(19):7324-7331. doi: 10.1039/d4sc00487f. eCollection 2024 May 15.
7
Infantile Monosialoganglioside2 (GM2) Gangliosidosis With Concurrent Bronchopneumonia: An Extraordinary Case of Tay-Sachs Disease.婴儿期单唾液酸神经节苷脂2(GM2)神经节苷脂沉积症并发支气管肺炎:一例特殊的泰-萨克斯病病例
Cureus. 2024 Jan 7;16(1):e51797. doi: 10.7759/cureus.51797. eCollection 2024 Jan.
8
Innate immune sensing of lysosomal dysfunction drives multiple lysosomal storage disorders.溶酶体功能障碍的先天免疫感应导致多种溶酶体贮积症。
Nat Cell Biol. 2024 Feb;26(2):219-234. doi: 10.1038/s41556-023-01339-x. Epub 2024 Jan 22.
9
A computational approach to analyzing the functional and structural impacts of Tripeptidyl-Peptidase 1 missense mutations in neuronal ceroid lipofuscinosis.一种分析三肽基肽酶 1 错义突变对神经元蜡样脂褐质沉积症的功能和结构影响的计算方法。
Metab Brain Dis. 2024 Apr;39(4):545-558. doi: 10.1007/s11011-024-01341-8. Epub 2024 Jan 8.
10
Assessing the integrity of auditory sensory memory processing in CLN3 disease (Juvenile Neuronal Ceroid Lipofuscinosis (Batten disease)): an auditory evoked potential study of the duration-evoked mismatch negativity (MMN).评估 CLN3 病(少年神经元蜡样脂褐质沉积症(Batten 病))听觉感觉记忆处理的完整性:时长诱发失匹配负波(MMN)的听觉诱发电位研究。
J Neurodev Disord. 2024 Jan 6;16(1):3. doi: 10.1186/s11689-023-09515-8.
真核起始因子 2α/激活转录因子 4 通路对于应激诱导的自噬基因表达至关重要。
Nucleic Acids Res. 2013 Sep;41(16):7683-99. doi: 10.1093/nar/gkt563. Epub 2013 Jun 26.
4
Therapeutic approaches for lysosomal storage diseases: a patent update.溶酶体贮积症的治疗方法:专利更新
Recent Pat CNS Drug Discov. 2013 Aug;8(2):91-109. doi: 10.2174/15748898113089990002.
5
Imaging findings of mucopolysaccharidoses: a pictorial review.黏多糖贮积症的影像学表现:图像综述。
Insights Imaging. 2013 Aug;4(4):443-59. doi: 10.1007/s13244-013-0246-8. Epub 2013 May 5.
6
The role of nonsense-mediated decay in neuronal ceroid lipofuscinosis.Nonsense-Mediated Decay 在神经元蜡样脂褐质沉积症中的作用。
Hum Mol Genet. 2013 Jul 1;22(13):2723-34. doi: 10.1093/hmg/ddt120. Epub 2013 Mar 28.
7
Migalastat HCl reduces globotriaosylsphingosine (lyso-Gb3) in Fabry transgenic mice and in the plasma of Fabry patients.Migalastat HCl 可降低法布里转基因小鼠和法布里病患者血浆中的神经酰胺三己糖苷(溶酶体神经酰胺三己糖苷)。
PLoS One. 2013;8(3):e57631. doi: 10.1371/journal.pone.0057631. Epub 2013 Mar 5.
8
Hydrocephalus in mucopolysaccharidosis type VI successfully treated with endoscopic third ventriculostomy.通过内镜下第三脑室造瘘术成功治疗的 VI 型黏多糖贮积症脑积水。
J Neurosurg Pediatr. 2013 Mar;11(3):327-30. doi: 10.3171/2012.11.PEDS11419. Epub 2013 Jan 11.
9
Cathepsin F mutations cause Type B Kufs disease, an adult-onset neuronal ceroid lipofuscinosis.组织蛋白酶 F 突变导致 B 型 Kufs 病,一种成年起病的神经元蜡样脂褐质沉积症。
Hum Mol Genet. 2013 Apr 1;22(7):1417-23. doi: 10.1093/hmg/dds558. Epub 2013 Jan 7.
10
Spinal cord compression in Maroteaux-Lamy syndrome: case report and review of the literature with effects of enzyme replacement therapy.马罗-拉米综合征中的脊髓压迫症:病例报告及文献综述并探讨酶替代疗法的效果
Pediatr Neurosurg. 2012;48(3):191-8. doi: 10.1159/000345635. Epub 2012 Dec 21.